Trial Profile
Prospective study evaluating the quality of life in dialysis patients with end stage renal disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2010
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 16 Apr 2010 New trial record